NasdaqGS:ACHC

Stock Analysis Report

Acadia Healthcare Company

Executive Summary

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Snowflake

Fundamentals

Moderate growth potential and overvalued.


Similar Companies

Share Price & News

How has Acadia Healthcare Company's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

10.7%

NasdaqGS:ACHC

0.8%

US Healthcare

1.3%

US Market


1 Year Return

-10.0%

NasdaqGS:ACHC

-8.2%

US Healthcare

2.0%

US Market

ACHC underperformed the Healthcare industry which returned -8.2% over the past year.

ACHC underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

ACHCIndustryMarket
7 Day10.7%0.8%1.3%
30 Day16.2%-1.5%3.9%
90 Day-6.5%-0.5%3.4%
1 Year-10.0%-10.0%-6.8%-8.2%4.2%2.0%
3 Year-37.4%-37.4%30.2%24.9%47.2%37.6%
5 Year-38.0%-38.0%63.6%53.9%60.5%42.9%

Price Volatility Vs. Market

How volatile is Acadia Healthcare Company's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Acadia Healthcare Company undervalued based on future cash flows and its price relative to the stock market?

1.16x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Acadia Healthcare Company's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Acadia Healthcare Company's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Acadia Healthcare Company is loss making, we can't compare its value to the US Healthcare industry average.

Acadia Healthcare Company is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Acadia Healthcare Company, we can't assess if its growth is good value.


Price Based on Value of Assets

Acadia Healthcare Company is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Acadia Healthcare Company expected to perform in the next 1 to 3 years based on estimates from 14 analysts?

28.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Acadia Healthcare Company's revenue is expected to grow by 4.6% yearly, however this is not considered high growth (20% yearly).

Acadia Healthcare Company's earnings are expected to grow significantly at over 20% yearly.

Acadia Healthcare Company's revenue growth is positive but not above the United States of America market average.

Acadia Healthcare Company's earnings growth is expected to exceed the United States of America market average.

Acadia Healthcare Company's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Acadia Healthcare Company is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Acadia Healthcare Company performed over the past 5 years?

-20.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Acadia Healthcare Company does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Acadia Healthcare Company's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Acadia Healthcare Company's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Acadia Healthcare Company has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Acadia Healthcare Company has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Acadia Healthcare Company improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Acadia Healthcare Company's financial position?


Financial Position Analysis

Acadia Healthcare Company is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Acadia Healthcare Company's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Acadia Healthcare Company's level of debt (132.2%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (63.9% vs 132.2% today).

Debt is not well covered by operating cash flow (10%, less than 20% of total debt).

Acadia Healthcare Company is making a loss, therefore interest payments are not well covered by earnings.


Balance Sheet

High level of physical assets or inventory.

Debt is not covered by short term assets, assets are 0.1x debt.


Next Steps

Dividend

What is Acadia Healthcare Company's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Acadia Healthcare Company's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Acadia Healthcare Company's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Acadia Healthcare Company has not reported any payouts.

Unable to verify if Acadia Healthcare Company's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Acadia Healthcare Company has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Acadia Healthcare Company's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Acadia Healthcare Company's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure


CEO

Debbie Osteen (63yo)

0.8yrs

Tenure

US$387,500

Compensation

Ms. Debra K. Osteen, also known as Debbie, has been Chief Executive Officer and Director of Acadia Healthcare Company, Inc. since December 16, 2018. Ms. Osteen led Universal Health Services, Inc’s Behavior ...


CEO Compensation Analysis

Debbie's remuneration is lower than average for companies of similar size in United States of America.

Insufficient data for Debbie to compare compensation growth.


Management Age and Tenure

0.8yrs

Average Tenure

55yo

Average Age

The average tenure for the Acadia Healthcare Company management team is less than 2 years, this suggests a new team.


Board Age and Tenure

6.7yrs

Average Tenure

63yo

Average Age

The tenure for the Acadia Healthcare Company board of directors is about average.


Insider Trading

More shares have been bought than sold by Acadia Healthcare Company individual insiders in the past 3 months.


Recent Insider Transactions

BuyUS$530,66009 Sep 19
Debra Osteen
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares20,000
Max PriceUS$26.53

Ownership Breakdown


Management Team

  • Chris Howard (52yo)

    Executive VP

    • Tenure: 8.6yrs
    • Compensation: US$1.79m
  • Catherine McDonald

    President of the Clinic - Acadia Vermilion Hospital

    • Tenure: 23.7yrs
  • Pam Broughton

    Chief Executive Officer of Acadia Pathways Hospital

    • Tenure: 0yrs
  • Robert Swinson

    Vice President of Financial Operations - Eastern Division

    • Tenure: 0yrs
    • Compensation: US$284.06k
  • Laurence Harrod (63yo)

    Executive Vice President of Finance

    • Tenure: 0.08yrs
  • Isa Diaz

    Senior Vice President of Strategic Affairs

    • Tenure: 0.7yrs
  • David Duckworth (39yo)

    Chief Financial Officer

    • Tenure: 7.2yrs
    • Compensation: US$1.74m
  • Gretchen Hommrich

    Director of Investor Relations

    • Tenure: 0yrs
  • Debbie Osteen (63yo)

    CEO & Director

    • Tenure: 0.8yrs
    • Compensation: US$387.50k
  • John Hollinsworth (55yo)

    Executive Vice President of Operations

    • Tenure: 0.2yrs

Board Members

  • Reeve Waud (56yo)

    Chairman & Lead Director

    • Tenure: 0.8yrs
    • Compensation: US$292.01k
  • E. Bissell (59yo)

    Independent Director

    • Tenure: 6.7yrs
    • Compensation: US$284.01k
  • William Grieco (66yo)

    Independent Director

    • Tenure: 8.4yrs
    • Compensation: US$287.01k
  • William Petrie (72yo)

    Independent Director

    • Tenure: 6.8yrs
    • Compensation: US$269.51k
  • Vicky Gregg (64yo)

    Independent Director

    • Tenure: 3.3yrs
    • Compensation: US$269.51k
  • Wade Miquelon (54yo)

    Independent Director

    • Tenure: 7.7yrs
    • Compensation: US$274.51k
  • Debbie Osteen (63yo)

    CEO & Director

    • Tenure: 0.8yrs
    • Compensation: US$387.50k

Company Information

Acadia Healthcare Company, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Acadia Healthcare Company, Inc.
  • Ticker: ACHC
  • Exchange: NasdaqGS
  • Founded: 2005
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$2.830b
  • Shares outstanding: 88.52m
  • Website: https://www.acadiahealthcare.com

Number of Employees


Location

  • Acadia Healthcare Company, Inc.
  • 6100 Tower Circle
  • Suite 1000
  • Franklin
  • Tennessee
  • 37067
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ACHCNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDNov 2011
7RADB (Deutsche Boerse AG)YesCommon StockDEEURNov 2011

Biography

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare faciliti ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:14
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.